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Abstract
Osmolytes are naturally occurring small organic molecules present in all king-
doms of life. These organic molecules are accumulated by living systems to cir-
cumvent stress conditions. A number of human diseases have been grouped under 
the protein-misfolding diseases. These entire diseases share the same hallmarks of 
the presence of cellular inclusions and plaques that are deposited in the cells and 
tissues affected by the disease. These misfolded forms of protein are responsible for 
initiating toxic cascades in the cell, causing vesicle dystrafficking, synaptic and cell 
organelle dysfunction, and ultimately cell death. Published results suggest that cells 
regulate many biological processes such as protein folding, protein disaggregation, 
and protein-protein interactions via accumulation of specific osmolytes. Since, as 
of now, complete cure for these protein-misfolding disorders does not exist; there-
fore, it becomes increasingly important to review the recent works on this aspect 
to develop strategies for therapeutics. It has been shown that certain osmolytes can 
prevent the proteins from misfolding. Thus, osmolytes can be utilized as therapeu-
tics for such diseases. In this review article, we discuss the role of naturally occur-
ring osmolytes in various forms of amyloidosis associated with human diseases.
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1. Introduction
Organisms in all the phylum of life experience stress conditions (heat, salinity, 
drought, etc.) of various kinds at one or more point in their life cycle. To survive 
such environmental assaults, the living forms during the course of evolution have 
developed a number of strategies. One such strategy that has been employed nearly 
by all kingdoms of life is the accumulation of osmolytes to evade various forms 
of stress. The osmolytes are low molecular weight compounds of organic nature 
[1–3]. These osmolytes are also termed as chemical chaperones due to their inher-
ent ability to cause proper protein folding. These stabilizing molecules, osmolytes, 
have been grouped into various categories by different classification schemes. The 
most commonly followed classification of these molecules is based on their chemi-
cal nature: polyols (sorbitol, myo-inositol, glycerol, etc.), amino acids and their 
derivatives (taurine, glycine, alanine, etc.), and methyl ammonium compounds 
(glycine betaine, TMAO, sarcosine, etc.). Another most common way of classifying 
these molecules is based on their ability to modulate protein function and stability: 
compatible osmolytes and counteracting osmolytes. It has been observed that the 
compatible class of osmolytes at 25°C causes changes in the stability of protein but 
does not have significant effect on the function [4–8]. In contrast to the compatible 
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class of osmolytes, the counteracting osmolytes modulate both the stability and 
functional activity of proteins. It has also been observed that counteracting osmo-
lytes protect proteins (in terms of both stability and function) by neutralizing the 
inactivating and destabilizing effects of urea on cellular proteins [9–14]. Lower 
vertebrates such as cartilaginous or elasmobranch fishes and coelacanth maintain 
their ionic homeostasis by accumulating large concentration of urea. Similarly, in 
the mammalian kidney, the cells of the inner medulla are normally exposed to high 
urea and salt concentration. In order to counteract the deleterious effect of urea on 
the structure and function of macromolecules, it has been proposed that marine 
fishes and cells of renal medullary cells adopt their unusual environment by accu-
mulating osmolytes such as TMAO, glycine betaine and glycerophosphorylcholine, 
etc. [15–18]. The term “protective” has also been used to define osmolytes since 
these molecules poses the capability to stabilize proteins under conditions, which 
are deleterious to their structure [19–27]. Osmolytes have also been implicated in 
stabilizing proteins that are less stable and also cause refolding of proteins that have 
been misfolded [28–30]. By using different experimental approaches such a differ-
ential scanning calorimetry or spectroscopic methods, researchers have calculated 
the preferential interaction parameters, which are based on free energy transfer 
methods of protein backbone in the presence and absence of osmolytes and, on this 
account, they proposed different protein-solvent mechanisms such as preferential 
hydration, preferential exclusion, preferential binding mechanism of stabilization, 
and destabilization of the unfolded state of the proteins [31].
Many reports describe the application of osmolytes in a number of mammalian 
disease models. The fact is that osmolytes play an important role in the protein 
quality control system (PQC) for maintaining homeostasis of the cell. Additionally, 
osmolytes have also been implicated in modulating the proteostasis, in controlling 
the degradative pathways of normal proteins and also the aggregation pathways 
of misfolded proteins. These osmolytes have also been reported to be able to act as 
therapeutic agents for the treatment of various pathophysiologic conditions associ-
ated with formation of protein aggregates. Importance of osmolytes in various types 
of diseases related to amyloidosis has also come to light. This review is designed 
to address all the clinical implications of osmolytes toward amyloidosis-related 
diseases with special emphasis on the amyloidosis related to α-synuclein.
2. How osmolytes modulate structure and stability of proteins?
The cells remain viable only when the protein residing in them retain their 
native structure, under normal conditions of pH and temperature [1]. The proteins 
adopt numerous three-dimensional arrangement of their polypeptide chains as 
is required by the cell to carry out its functions and, hence, maintain its viability 
[32]. The polypeptides, which are to be degraded, are always found to adopt a less 
stable conformation as compared to more stable and functional proteins [32]. 
For the cell to maintain homeostasis, it is very essential that a constant balance 
should be maintained between rate of degradation and production of proteins. 
A small change in this balance will lead to the development of disease [1, 33, 34]. 
Osmolytes have an inherent property to either stabilize or sometimes destabilize 
the three-dimensional polypeptide conformations; hence, they are able to modify 
protein homeostasis. A very fine relationship that exists between degradation and 
proper folding of proteins that are either unstable or has misfolded is what makes 
cell viable. The quality of the polypeptides is dictated by the events that occur in the 
early pathways of secretion, nucleus, and cytoplasm where the polypeptide assumes 
its proper functional native conformation and assembly. The proteins, which 
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attain conformationally less stable structures, undergo proteasomal degradation 
[35]. In addition, the misfolded or pathological protein aggregates downregulate 
proteasomal activity, which leads to neurodegenerative diseases. Now the role of 
osmolytes comes into action. They act as molecules of surveillance, trying to find 
such misfolded molecules and enabling them to attain proper functional conforma-
tion, leading to increment in homeostasis of less stable proteins. But many of the 
osmolytes come under the category of destabilizers, which promote protein degra-
dation of highly stable or fibrillar conformations. It, therefore, seems very logical 
for cells to accumulate osmolytes, which have both the property of stabilizing and 
destabilizing, to regulate proteins homeostasis. Numerous research groups have 
demonstrated significant role of osmolytes as regulators of protein homeostasis 
[28, 32, 36–42]. It has been clearly demonstrated that in the presence of the stabiliz-
ing osmolytes, the misfolded proteins can be saved from proteolytic pathways by 
making them refold back to native structures. If we can modulate the cell’s ability to 
accumulate osmolytes through any process, then it will have a profound impact on 
the stability and functions of proteins and enzymes in maintaining the homeostasis 
of the cell. The methylamine group of osmolyte such as betaine has dual role at 
two different molar concentrations; it acts as a denaturant at high molarity and as 
a stabilizer at low molarity [43]. The pathological conditions associated with age 
or that have genetic relations are all due to the errors involved in the breakdown 
of misfolded polypeptides. These misfolded polypeptides are associated together 
to form nucleation-dependent polymerization to form fibrillar structures, which 
leads to amyloid-associated diseases [44]. These pathophysiological conditions 
can be combined under one title, i.e., the protein conformational diseases. Many 
diseases fall under this category and include serpin-deficient disorders, Alzheimer’s 
disease, cystic fibrosis, transmissible spongiform encephalitis, hemolytic anemia, 
Huntington disease, diabetes type II, amylotropic lateral sclerosis, dialysis-related 
amyloidosis, and Parkinson’s disease [9, 23]. Therefore, if we could devise certain 
methods to use these osmolytes so that it will shift the changes from non-native 
conformations to native conformations of protein, then many misfolded disorders 
can be treated. Even the destabilizing osmolytes can be utilized to remove the 
fibrillar structures of polypeptides formed inside the cell. Two amino acids, lysine 
and arginine, are often used in the solubilization of inclusion bodies and fibrillar 
structures [45–47]. Thus, osmolytes that stabilize the polypeptides are also known 
as good refolders [48]. Additionally, many proteins are known to bind to particular 
proteins, subsequently modifying the native conformation, as in posttranslational 
modification reactions [49]. A large number of polypeptides are shown to bind with 
arginine and the methyl group of betaine to regulate their biological function [50].
3.  Osmolytes induce misfolded protein to attain functional folded 
structure
It is a very well-known fact that the primary sequence of amino acid residues 
in the polypeptide chain code for the three-dimensional structure of the protein, 
which in turn determines the functional structure and activity of protein through 
different complex pathways of protein folding [51]. It becomes very essential that 
no error occurs during the protein folding through this pathway, but if it will move 
to off-pathway, then it can lead to the formation of a misfolded protein. Since these 
misfolded proteins lose their original function, they are deleterious to function and 
survival of cell [52]. The formation of such misfolded proteins may be due to muta-
tion in its gene or error in the pathway of protein folding, and these are recognized 
by the cells as abnormal and are subjected to undergo degradation in the PQC 
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system. The loss of proteins by subjecting them to degradation may result in loss 
of function [53]. The other reason cited for the loss of function was that misfolded 
proteins tend to accumulate in the endoplasmic reticulum (ER), which is considered 
to be a type of defect associated with trafficking pathway and resulting in func-
tional deficiency. Functional deficiency can be explained by taking the example of 
α1-antitrypsin (α1-AT), which is an extracellular protein synthesized in the ER. The 
mutant form of this protein is due to altered structure, which aborts the transporta-
tion mechanism of the protein in the ER and hence gets accumulated in ER leading 
to α1-antitripsin deficiency. Many reports have been shown that misfolded protein 
accumulated in the ER may lead to the development of environmental stress and 
subsequently, developing into the ER-associated disease [28]. Another hypothesis 
put forward to explain the functional deficiency is caused due to the presence 
of mutant protein. The mutant protein fails to fold to its properly folded native 
structure and forms a misfolded structure that may oligomerize and may further 
form aggregates. These oligomers and aggregates induce oxidation stress in the cells, 
thereby, deleteriously affecting the physiological processes of cells; i.e., they may 
cause enhancement in function of certain proteins, which is the case in pathophysi-
ological state that causes neurodegeneration [54].
Many reports demonstrated that when osmolytes were added to the solution 
containing misfolded mutant proteins, their native function was restored. Many of 
these studies have also shown that specific osmolytes are able to assist correct folding 
of misfolded proteins. This in turn prevents their degradation, thus increasing their 
intracellular function [32, 36, 38, 39, 41, 42]. A study had shown that treating the 
mammalian fibroblast cell line with media containing 4-PBA and glycerol reduced 
the concentration of mutant form of α1-ATZ in the cells [55], but this effect was not 
observed when TMAO, D2O, and betaine were added to the culture media and resulted 
in the rise in the levels of native α1-ATZ in the cells when osmolytes were present 
[28, 55]. Similarly, different classes of osmolytes were found to correct the defects in 
folding of protein and restore protein function of phenylalanine hydroxylase [29]. 
For instance, in the protein p53, which is a protein involved in suppression of tumor 
formation, mutation of p53, A125V causes temperature sensitivity and when such cells 
are cultured at 32°C, the permissive temperature, the p53 protein is active and is found 
localized in the nucleus [37]. However, cells, which are grown at higher temperatures 
(nonpermissive condition), the p53 protein becomes inactive and gets localized in the 
cytosol. It was also observed that when 75 mM TMAO, 0.6 M glycerol, or D2O, were 
added to the culture media, the p53 protein is relocated in the nucleus even at higher 
temperature. This could be explained as the osmolytes cause the correct folding of the 
mutant protein; therefore, at higher temperature also, the p53 protein remains correctly 
folded and hence functional in the presence of TMAO, glycerol, and D2O. Interestingly, 
when the osmolytes where removed from these cells, the p53 protein became tem-
perature sensitive. Aquaporin-2 (AQP-2) is a vasopressin protein found in the kidney 
collecting duct. It functions as a water channel that carries water molecules across the 
cell membrane. The mutation in AQP2 gene results in the misfolding of Aquaporin-2 
protein which leads to the development of diabetes insipidus in mammals. But when 
glycerol (1 M) was added in the cell culture, glycerol restores the folded structure and 
hence the proper translocation of this protein in the cell [56]. The cells, which have the 
mutant protein Src kinase (pp60src), do not attain the correct functional conformation 
at higher temperatures (nonpermissive), and therefore, it is unable to modify the cells. 
Interestingly, when the cells grow at nonpermissive temperatures in the presence of 
glycerol, this mutant protein is still capable of transforming the cells. Thus proving that 
glycerol is able to restore the correct conformation of protein and hence its function. 
Another study showed that the mutant form of ubiquitin ligase, ts-E1, which remains 
nonfunctional at higher temperature, causes loss of cell growth because of unspecific 
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degradation of proteins. But, when glycerol or TMAO was added, these osmolytes 
restored the correct conformation of the protein and hence normal growth of cells [57]. 
In all the above experiments, which were performed in the mammalian cell culture, 
bacterial, or yeast systems, the addition of glycerol to media assisted correct fold-
ing of mutant proteins and restored their normal biological activity [36, 58]. These 
osmolytes have also been implicated in increasing the expression of certain proteins 
(P-glycoprotein) in cancer cells [59], which acted as pumps for exporting the drugs out 
of the cells [60]. The human P-glycoprotein expression levels were observed to be very 
low [61], but when osmolytes were added in the culture media, the expression level of 
the protein in cells was enhanced [62].
4. Osmolytes play important role in preventing protein aggregation
When the proteins get misfolded, the hydrophobic groups present in the 
polypeptide chain, which earlier had remained buried in the three-dimensional 
structure of native protein, are exposed to the surrounding solvent. The exposure 
of the hydrophobic groups to the exterior of the protein causes intermolecular 
binding between these exposed groups. When these misfolded proteins reach a 
critical concentration inside the cell, the process of oligomerization and subsequent 
aggregate formation starts. The sequence of amino acid residues in the polypeptide 
chain changes when the proteins are exposed to harsh conditions, for example, high 
temperature or exposure to oxidation stress. These changes in the primary structure 
of proteins may be caused due to modification of RNA or defects during translation 
process of proteins, and all of these factors increase the chances for the protein to 
aggregate [63, 64]. These aggregation products of protein have very low solubility 
in the surrounding physiological solvent. These protein aggregates remain stable 
metabolically, and they may exist in the cells in the form of amyloids or in confor-
mations, which are amorphous [65]. Many research groups have focused their work 
on the key factors involved in the process of aggregation of proteins and subsequent 
development of the disease. It is well known that the kinetics of aggregate forma-
tion follows a sigmoid curve and comprises of three stages: (i) lag phase that corre-
sponds to structural transformation within monomer leading to the appearance of 
aggregation-prone partially folded species, (ii) exponential phase that corresponds 
to self-association leading to the formation of oligomers, and (iii) stationary phase 
that leads to the formation of aggregates [66]. The amount of aggregation products 
that are formed and deposited inside the cell is determined by the biosynthesis rate, 
stability, compactness of the protein, and also the number of hydrophobic groups 
present in the protein that are exposed to the exterior environment [67]. One of 
the characteristic features of all the diseases, which involve formation of protein 
aggregates, is the increase in the β-helical content of the protein with subsequent 
decrement in the α-helical content of the protein secondary structure [68]. In the 
field of medicine, this phenomenon of aggregate formation of protein has now 
acquired a lot of attention due to its implication in many of the human diseases 
including, neurodegenerative, metabolic, cardiovascular disorders, etc. [69–77]. It 
has also been reported that a particular amino acid sequence or three-dimensional 
structure of protein is involved in a specific disease that is associated with aggregate 
formation [78–80]. Surprisingly, many of the peptides and proteins have not been 
found associated with any case of disease until and unless they are subjected to 
specific conditions or stress conditions to form aggregates. Hence, it is safe to say 
that it is the inherent property of all proteins to get aggregated [78–80].
Researchers have shown that proline acts as a wonder osmolyte against aggre-
gation of protein. In this instance, it was found that the aggregation of bovine 
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carbonic anhydrase inhibited at three molar concentrations of proline [81]. The 
inhibition of aggregation in the presence of proline can be explained that proline, a 
charged amino acid, might introduce an electrostatic repulsion in the interactions 
of the polypeptide chains at the very earlier stages of the aggregation process [82]. 
The protein huntingtin, which is polyglutamine-rich (polyQ ), is reported to get 
accumulated in the nucleus of cell. This type of amyloid deposition is a hallmark 
feature for the patients affected by Huntington disease (HD) [83]. An experiment 
with 21 days old mice, which were kept on trehalose solution diet till the day of 
killing, was observed with a significant reduction in the accumulation of misfolded 
protein Huntingtin [84]. Because of this, motor dysfunction associated with the 
disease was improved, which resulted in the extension of the life of HD transgenic 
mice used as models for the disease [84]. Many other laboratories reported the 
inhibition of aggregation in many different types of protein in the presence of 
proline for instance, chicken egg lysozyme [85], chicken liver fatty acid synthase 
[86], and rabbit skeletal muscle creatine phosphokinase [87]. But the existing 
reports also demonstrated that these osmolytes may in some instances promote the 
misfolding of protein leading to the aggregates formation or sometimes they have 
no effect at all on the process of protein aggregation. TMAO, an osmolyte, is one the 
best examples of such case. When RNase was subjected to refolding in the presence 
of TMAO, it increased the formation of aggregates [88]. In another study, it was 
found that glycine (at very high molarity) had no significant effect on the aggregate 
forming ability of chicken liver fatty acid synthase [86]. In addition, it could not 
also refold the chicken egg lysozyme [85]. Taurine, though was able to delay the 
fibrillation [89], had no effect on the aggregate morphology of glucagon [89]. 
Trehalose, on the other hand, has shown good potential to inhibit the fibrillation of 
many Aβ40 [90], yeast prion protein Sup35 [91]. In the models of oculopharyngeal 
muscular dystrophy in mouse, trehalose lowers down the levels of aggregation of 
protein [92]. In addition to the general role played by osmolytes in PQC system 
and hence in the disease etiology of multiple PQC-related diseases, there are some 
specific diseases that have been paid more attention and osmolyte strategy has been 
successful in their case, which are described below.
5. Osmolytes and process of amyloidosis
The process of fibril/aggregate formation in the process of amyloid forma-
tion is determined by the thermodynamic solubility of peptides. The solubility 
of the peptides depends on the structure and concentration relative to the critical 
concentration of the peptides. Above the solubility limit, the peptides formed a 
series of crystals and fibril structures to form amorphous aggregates. Two types of 
aggregates are formed based on their morphology: ordered (amyloids with β-rich 
proteins) and disordered (amorphous) [93, 94]. It was evident that the partial 
unfolding of the native state results in the formation of ordered aggregate structures 
[93, 95]. The intermediate formed during this partial unfolding has hydrophobic 
patches exposed to the exterior. These hydrophobic patches bind each other and 
lead to the formation of amyloids [80, 96, 97]. Several groups have reported that 
osmolytes have a great potential to suppress/inhibit this misfolding and subsequent 
fibril formation by proteins [98–102]. It has been very well demonstrated that these 
osmolytes increase the stability of proteins under conditions of heat stress by the 
mechanism of preferential hydration [99, 100, 103–105]. A number of reports exist, 
which demonstrate the use of these small molecule osmolytes as good therapeutic 
agents for the treatment of several protein-misfolding diseases [84, 106]. It is very 
interesting to note that in the presence of some osmolytes, proteins can also be 
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induced to form fibrils or aggregates under controlled conditions. One such enzyme 
is lysozyme, a model protein. This enzyme has been widely used for such kind of 
studies due to its small size and also since a lot of information related to structure 
and stability exists in the literatures. Since long, lysozyme has been considered a 
model protein to study the complexities of structure of protein as well as its func-
tion [107]. It also has been extensively studied to get information on the kinetics of 
enzyme action as well as on markers for protein-misfolding diseases [108].
Choudhary and coworkers prepared several amyloidogenic forms of lysozyme 
and subjected them to ThT-binding fluorescence spectroscopy [108]. Then they 
monitored the intensity of ThT fluorescence emission of lysozyme at the various 
stages of fibril and aggregate formation: nucleation, elongation, and saturation. 
This enabled them to assess the different stages of the fibril formation. To get a 
better understanding of the energetics of interaction of a particular osmolyte with 
the fibril at different stages of its formation, they performed isothermal titration 
calorimetry (ITC) studies. They also used transmission electron microscopy to see 
the morphology of these fibrils at different stages [108]. They found that osmolytes 
such as sarcosine, proline, TMAO, and 4-hydroxy-L-proline were able to inhibit 
the fibril formation of lysozyme [108]. Sarcosine and 4-hydroxy-L-proline were 
found to significantly prolong the start of the elongation stage of fibril formation. 
Interestingly, lysozyme showed amorphous aggregates in the presence of TMAO 
for more than 5 hours of incubation at a stretch. Similar results were obtained when 
observed under TEM. In another example, they used proline as a polar osmolyte 
and observed that an exothermal interaction was occurred in between lysozyme and 
proline at the stage of nucleation. However, at the elongation stage, the association 
of protein with proline was found to be less exothermic as compared to the pres-
ence of sarcosine [108]. Therefore, this study clearly demonstrated that osmolytes 
basically interact with polar protein at the nucleation stage. This is accounted as the 
major step for the inhibition of fibril formation [108].
Researchers found many difficulties in the detection of protein aggregates with 
respect to conformational patterns, nature of aggregates, and various structural 
fibrils forms. There are different spectroscopic methods such as UV visible, circular 
dichroism (CD), NMR, X-ray diffraction, etc., used in characterizing the conforma-
tional changes in the protein. Fluorescence dyes such as Thioflavin T and Congo red 
binding assays as well as antibodies are used as external probes for evaluating the 
physical properties of the aggregates.
Recently, Needham and coworkers developed bifunctional sensors for simulta-
neous detection of amyloid aggregates of α-synuclein and pathophysiological H2O2 
concentrations for oxidative stress. They also developed a new imaging method 
called single-aggregate visualization by enhancement (SAVE) to detect single-β-
sheet containing amyloid aggregate of α-synuclein using ThT [109].
Another group studied the fibrillation process in the presence of TMAO of the 
peptide NNQQNY (of Sup35 prion) by molecular dynamics simulation (MDS) 
method [110]. When the free surface energy of the formation of protofibril was 
observed, it showed three main basins which corresponded to the time when peptide 
was in solution, known as free state, the time when the peptide in the solution was 
interacting with the surface of the protofibril, known as the docked state and the 
last stage when the peptide gets tightly bound to the protofibril and thus becoming a 
part of fibril known as locked state [110]. When these studies were performed in the 
presence of TMAO, it was found that this osmolyte stabilized the locked state and 
thus acting as an aid in the process of aggregation [110]. When the associative reac-
tions of TMAO with each amino acid residue in the protein were studied in detail, 
it was found that TMAO interacted with each amino acid residue either directly or 
indirectly, and this was determined by nature of their side chain. It was also found 
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that the TMAO’s methyl groups interacted very strongly with the aromatic ring of 
tyrosine residues. In this study, they proposed that in the locked state, the tyrosine’s 
surface area of the peptide was not available to interact with TMAO. As a result of 
this, the tyrosine residue flips in such a way that it fluctuates the locking state of 
the protofibril of peptide, and this leads to destabilization of the folded and also 
the fibril state of proteins. The increase in the stability of peptide, which is locked 
in protofibril state in the presence of TMAO, is because of interactions, which are 
entropic in nature and indirectly with the peptide backbone of residues Gln and Asn. 
Both of these residues are important part of NNQQNY peptide [110].
Many research groups studied the aggregation properties of amyloid plaques, 
which are a central feature of Alzheimer’s disease. In this context, Aβ residues 
represent a common seed element for the nucleation of fibrillar structure, which 
leads to amyloid fibrils.
Researchers have shown various effects of osmolytes on the aggregation 
pathway of Aβ. For example, Trehalose was found to be a potential osmolyte, 
which reduces the Aβ-cytotoxicity by inhibiting its aggregate formation [90]. 
Another report demonstrated that sugar (sucrose) was able to slow down the 
growth of Aβ fibril. This osmolyte was found to block the racemization reac-
tion of D-aspartic acid [111], which is the main contributor to the formation of 
deposits of Aβ [112]. Cyclohexanehexol (inositol), a naturally-occurring cyclic 
polyol compound belonging to myo-inositol family of osmolyte, is found in 
foods such as nuts, beans, and fruits. McLaurin and coworkers [113, 114] had 
very clearly demonstrated that stereoisomers of cyclohexanehexol, for instance, 
myocyclohexanehexol, scyllo-cyclohexanehexol, and epi-cyclohexanehexol, 
are not only responsible for preventing the assembly of fibrils of Aβ, but also 
they cause the disassembly of fibrils that had been formed in earlier stage. They 
have also reduced the toxicity, which is caused by the formation of oligomeric 
structure in primary cultures of neuronal cells. It was also observed that out of 
three cyclohexanehexol stereoisomers, myo-cyclohexanehexol was the most 
abundant stereoisomers found in the brain, but the other two stereoisomeric 
forms, i.e., epi-cyclohexanehexol and scyllo-cyclohexanehexol, were found to be 
more effective in reducing the fibrillation of Aβ and its associated toxic effects 
[114]. When the epi-and scyllo-cyclohexanehexol stereoisomers were fed to the 
mouse models for TgCRND8, it was observed that it prevented the accumulation 
of Aβ oligomers (soluble and insoluble aggregates) in a dose-dependent way and 
subsequently, it reduced the toxicity associated with its deposition [115]. This 
caused a decrease in the symptoms and mortality associated with AD in these 
mice [115]. Administration of scyllo-cyclohexanehexol also caused reduction in 
the number of amyloid plaques in mice having an advanced stage of AD [116]. 
Another compound that is slightly different from the inositol is the inosose 
stereoisomer, which has a keto-group instead of hydroxyl group. These inososes 
are able to prevent Aβ fibrillation [117]. These osmolytes are found to modify the 
folding pathway of Aβ [118], and secondly, they may also compete for binding 
sites on Aβ. The stereoisomers of inosose and inositol act as competitors for the 
phosphatidylinositol binding sites on Aβ [115]. These lipids (phosphatidylinosi-
tol) are known to induce the process of oligomerization and fibril formation of 
Aβ [113, 117, 119, 120]. Additionally, osmolytes may cause upregulation of HSPs, 
chaperone expression [121], and that will cause increments in the efficiency of 
folding of proteins under conditions of stress [122, 123]. Therefore, we can say 
that these compounds (cyclohexanehexols) are potential candidates for the treat-
ment of AD-like pathological events in mice [124].
A study tried to investigate the role of osmolytes in the amyloid-associated 
aggregation model based on insulin (human) hormone protein. They found that 
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sorbitol, TMAO, and glycerol cause reduction in the rate of fibril formation by 
slowing down the process of unfolding of monomers. These experimental results 
showed a good correlation with volume exclusion principle applicable to polymer 
crowding. This voted for the need of rearrangement (conformational) of monomers 
prior to nucleation. This group used fluorescence correlation spectroscopy and 
showed that the aggregation of amyloid is not limited by diffusion, except under 
conditions where elevated levels of long-chain polymers of fibril are present. They 
demonstrated that the osmolytes, which had neutral charge at physiological condi-
tions, affected the tlag (i.e., the time required for the initiation of fibril formation) 
in a surface area (of osmolyte)-dependent fashion. This phenomenon is a result of 
the preferential interaction phenomenon of osmolytes [125].
6. Effects of osmolytes on α-synuclein
Human α-synuclein consists of 140 amino acid residues [126]. High concentra-
tions of this protein are found in brain, particularly, in the terminals of presynapse. 
This protein is expressed in thalamus, hippocampus, cerebellum, and substania 
nigra regions of brain [127]. This protein has three well-differentiated portions: 
the N-terminal domain, which is amphipathic in nature (residues 1–60), the 
nonamyloid-β component (NAC), which is hydrophobic in nature that constitutes 
the central region (residues 61–95), and C-terminal domain, which is acidic in 
nature (residues 96–140). The proteins belonging to the synuclein class do not have 
an ordered three-dimensional conformation; therefore, they are known as intrin-
sically disordered proteins (IDP) [128]. IDPs have a very random and unfolded 
structure, which induces the formation of protein aggregates, subsequently 
causing various human diseases [129]. This protein comprises a very significant 
part of Lewy’s bodies and lead to the development of PD and other pathologies 
that result from fibrillation of proteins [130]. Numerous reports have shown that 
when α-synuclein (monomer) undergoes a conformational change, which causes 
the beginning of aggregation in the brains affected with PD. Since, IDPs are very 
dynamic with regard to conformation as they attained, the design of drugs to 
inhibit their aggregation becomes difficult. Now, researcher groups are using REMD 
computational technique to investigate the folding and misfolding of different IDPs. 
The protein α- synuclein in its monomeric form has the features of typical IDPs. The 
main role of α-synuclein inside the cell is to act as a chaperone to assist in forming 
larger proteins [131], trafficking of vesicle, and neurotransmitters secretion [128]. 
In the adverse condition, α-synuclein undergoes changes in its conformation, which 
results in the beginning of the fibrillation process and this cause for the advent of 
PD [132, 133]. Therefore, it becomes very important to get a basic knowledge of 
mechanism of unfolding monomer of α-synuclein in order to prevent its fibrillation 
process.
Since it is very clearly reported in literature that urea denatures protein 
even at low concentrations, this effect of urea can be counteracted by many of 
the counteracting osmolytes [128, 134]. Based on this fact, Jamal and cowork-
ers [128] performed REMD simulations with the peptide of α-synuclein in 
the presence of urea and TMAO. Interestingly, they found that urea present 
with the peptide existed in an expanded conformation. But in the presence of 
TMAO, the peptide assumed a more compact conformation. They performed 
REMED on the TGVTAVA segment, of α-synuclein, in the presence of water 
(Synucleinwater), urea (Synucleinurea+water), and TMAO (SynucleinTMAO+water). 
They studied the different conformations attained by the segment, TGVTAVA, 
in the presence of water, urea, and TMAO. They obtained 18 replicas of the 
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protein segment (TGVTAVA) from the REMED analysis performed in tempera-
ture range of 300–350 K. When they calculated the root-mean-square deviation 
(RMSD) for all the three systems, they obtained variation in the values with 
each system, i.e., Synucleinwater, Synucleinurea+water, and SynucleinTMAO+water. 
These variations indicated that peptide assumed multiple conformations, 
under different conditions [128]. In this study, they demonstrated that 2 M 
TMAO and 5 M urea had significant different impact on the conformation 
adopted by protein in their presence. Urea promoted the formation of extended 
structures for Synucleinurea+water peptide, whereas, TMAO favored the forma-
tion of compact and folded forms of the SynucleinTMAO+water, peptide. The 
population density plot created as a function of average end-to-end distance 
(Ree) and radius of gyration (Rg) for all the three systems (Synucleinwater, 
Synucleinurea+water, and SynucleinTMAO+water) also demonstrated that extended 
structures were more populated in the presence of urea. On the contrary, 
only few extended conformations of peptide were observed in the presence of 
TMAO [128].
Uversky and coworkers [135] studied the effect of TMAO on the α-synuclein 
that was unfolded. They found that TMAO induced the α-synuclein to fold back to 
compact conformation and suggested a biphasic mechanism of α-synuclein [135]. 
Another group used an all-atom molecular dynamic simulations and essential 
dynamics approach to study the dynamics of folding of unfolded α-synuclein 
present in water [136]. They used a monomer, dimer, and a tetramer of α-synuclein 
forms in their study. They found that the α-synuclein adopted globular conforma-
tion, which consisted of random coils in addition to β-bridges for the monomers 
used in the study. When dimers were used, it comprised mainly of stable β-sheets 
to attain stable conformation. But in case of the tetramers, it had less number of 
β-sheets. Another group used REMD approach to investigate the oligomer forma-
tion by α-synuclein peptide (residues 71–82), trimers, and tetramers. They found 
that with increase in size of the peptide, i.e., from dimer to tetramer, the conforma-
tion was stabilized [137]. It was found that in the system consisting of synuclein 
with urea and water, the number of hydrogen bonds that were formed with the 
external surface of peptide was decreased.
Ferron and coworkers [138] studied the counteraction of urea-induced 
denaturation of α-synuclein by TMAO with the help of single-molecule Förster 
resonance energy transfer (FRET) technique. They found that TMAO indeed 
had the ability to induce the shifting of the expanded α-synuclein toward a more 
compact form in the presence of urea [138]. Interestingly, their study clearly 
demonstrated that 2:1 molar ratio of urea and TMAO had negligible effect on the 
dimensions of the protein. This study explains that a simple interplay of interac-
tions exists between urea and TMAO with the protein [138]. Through this report, 
the group demonstrated that α-synuclein tends to adopt structures (expanded or 
compact) in the presence of osmolytes (denaturing or protecting). But in doing 
so, a very clear cooperative transition in structure was not observed [138]. This 
study has also suggested that osmolytes protect the protein against the deleterious 
effects of urea in specific ratios. These osmolytes in this case are able to protect 
the function and structure of proteins by accommodating the changes in the ratios 
of osmolytes to urea, and this does not require any kind of regulation on the part 
of the molar concentrations of these solutes present in the cell [138]. Again, the 
results in the study demonstrated that the counteraction phenomenon holds true 
even for the protein, which have not evolved in the urea-osmolyte systems [138]. 
The hypothesis of “superposition of ensembles” [139], which states that when 
osmolytes are added to a system, they do not induce the formation of a new state, 
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but they induce the changes in the population of protein conformations present in 
a particular state. For example, TMAO has been found to promote the formation 
of tau protein’s ordered structures by merely shifting the populations of existing 
monomer conformations [139].
7. Conclusion and perspective
It is now clear that osmolytes would be of immense application in large 
number of human diseases. It is now important to look for the strategies for 
tissue-specific delivery of osmolytes. Since osmolytes are accumulated under 
different disease conditions, identifying specific osmolytes with respect to 
upregulation or downregulation in the cell under particular diseases will be 
useful for the selective use of osmolytes against a disease. This will benefit for 
the use of osmolytes as a strategy for the diagnostic purposes. Large volume 
of the work carried out to investigate the effect of individual osmolyte on the 
aggregation behavior or misfolding of proteins is still confined to case-by-case 
analysis. Understanding the effect of one osmolyte against the different proper-
ties of protein aggregation, misfolding, or folding pathway will yield several 
additional insights for the therapeutic intervention of conformational diseases. 
Since accumulating a particular osmolyte may become toxic to cells [48], using 
mixtures of different osmolytes in specific molar ratios may help to increase 
the efficacy and/or reduce toxicity of accumulated osmolytes. In this respect, 
Poddar et al. [140] showed that the sum effect of individual sugars is always 
more effective or stabilizing on the protein than its higher respective sugars. 
Thus, using different specific mixtures of osmolytes against a particular amy-
loid aggregates such as α-synuclein may provide a good strategy for therapeutic 
treatment of neurological disease.
Large number of literatures showed the mechanism of the effect of specific 
osmolytes on different fibrillar/aggregated states, native, and denatured state 
of proteins through different experimental approaches directly or indirectly or 
through a combination of the two methods. Thus, the detailed information on 
the mechanism of action of each osmolytes with the protein at different stages 
from nucleation to fibrillation under such condition and this information would 
help in making a rational drug as pharmaceutical chaperones for the prevention 
and cure of diseases. In this respect, recently, Pradhan and coworkers designed 
nanoparticle forms of sugar/amino-based osmolytes that not only inhibit the 
lysozyme aggregation in vitro but also inhibit the mutant huntingtin protein 
aggregation in vivo, and thus, the chaperoning activity of these nanoparticle-
conjugated osmolytes against protein aggregation increased a 1000 order of 
magnitude [141].
Thus, extensive efforts are still needed in the direction of mechanism of osmo-
lytes, their unusual properties against each protein, new methods for investigating 
a correlation between aggregation of protein with other metabolic function in the 
cells, and designing new conjugated or drugs based on osmolytes which show better 
chaperoning activity for prevention of aggregation-associated diseases.
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